Juan C Alvarez

This inventor holds 15 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent, primarily in Immunotherapy Innovations. Top assignees: Alkermes, Inc., Alkermes Pharma Ireland Limited. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan C Alvarez. Retrieved from https://idiyas.com/inventor/juan-c-alvarez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 4)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 52(Granted Patents)

Location History:

Chelmsford, MA (US) (2015 - 2021)
Lincoln, MA (US) (2019 - 2022)

Company Filing History:

Alkermes Pharma Ireland Limited

patents

Years Active: 2015-2022

Loading Chart...

Areas of Expertise:

IL-10 Modulation

Immunostimulatory Properties

Anti-Inflammatory

Prodrugs

Secondary Amine Compounds

Fusion Polypeptides

Mucin-Domain Linkers

Pain Treatment

Agonists

Antagonists

Ligands

Polypeptide Linkers

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11534480 - Compositions and methods for modulating IL-10 immunostimulatory and anti-inflammatory properties (2022-12-27),

2. 11225490 - Prodrugs of secondary amine compounds (2022-01-18),

3. 11180455 - Compounds for the treatment of pain (2021-11-23),

4. 10954250 - Prodrugs of secondary amine compounds (2021-03-23),

5. 10881741 - Single chain Fc fusion proteins (2021-01-05),

6. 10604489 - Compounds for the treatment of pain (2020-03-31),

7. 10407481 - Ligands modified by circular permutation as agonists and antagonists (2019-09-10),

8. 10335459 - Compositions for modulating IL-10 immunostimulatory and anti-inflammatory properties (2019-07-02),

9. 10183979 - Fusion polypeptides comprising mucin-domain polypeptide linkers (2019-01-22),

10. 10023623 - Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide (2018-07-17),

11. 9428563 - Ligands modified by circular permutation as agonists and antagonists (2016-08-30),

12. 9359415 - Ligands modified by circular permutation as agonists and antagonists (2016-06-07),

13. 9296801 - Fusion polypeptides comprising mucin-domain polypeptide linkers (2016-03-29),

14. 9156897 - Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide (2015-10-13),

15. 8969337 - Prodrugs of secondary amine compounds (2015-03-03),

Title: The Innovative Journey of Juan C Alvarez: Pioneering Medical Solutions

Introduction: Juan C Alvarez, a prolific inventor based in Lincoln, MA, has made significant contributions to the field of medical science with 15 patents to his name. His groundbreaking work has focused on developing compositions and methods to modulate IL-10 immunostimulatory and anti-inflammatory properties, as well as the creation of prodrugs of secondary amine compounds.

Latest Patents: Alvarez's most recent patents showcase his expertise in the field. One such invention involves compositions and methods for modulating the immunostimulatory properties of IL-10. These novel scIL-10 polypeptides offer a unique amino acid sequence arrangement, coupled with fusion partners, to enhance their efficacy in modulating immune responses. Additionally, his work on prodrugs of secondary amine compounds signifies a pioneering approach towards drug delivery and efficacy.

Career Highlights: Alvarez's impressive career spans various renowned companies, including Alkermes, Inc. and Alkermes Pharma Ireland Limited. Throughout his tenure, he has consistently pushed the boundaries of innovation in the pharmaceutical industry, leading groundbreaking research initiatives and patent acquisitions.

Collaborations: Alongside his dedicated solo work, Alvarez has also collaborated with esteemed colleagues such as Demetri Theodore Moustakas and Heather C Losey. These partnerships have not only enriched his professional journey but have also resulted in collaborative patents that have left a lasting impact on the industry.

Conclusion: Juan C Alvarez's innovative prowess, coupled with his relentless pursuit of medical solutions, continues to shape the landscape of pharmaceutical research. His patents stand as a testament to his dedication to advancing medical science and improving patient outcomes. With a promising career marked by innovation and collaboration, Alvarez remains a beacon of inspiration in the world of inventors and visionaries.

Profile summary based on public USPTO records.